Kilitch Drugs (India) consolidated net profit declines 60.12% in the June 2024 quarter

Net profit of Kilitch Drugs (India) declined 60.12% to Rs 1.34 crore in the quarter ended June 2024 as against Rs 3.36 crore during the previous quarter ended June 2023. Sales declined 8.51% to Rs 33.45 crore in the quarter ended June 2024 as against Rs 36.56 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	33.45	36.56	-9
OPM %	4.96	16.90	-
PBDT	2.50	5.24	-52
PBT	1.65	4.53	-64
NP	1.34	3.36	-60